ReP USP - Resultado da busca

Artigo de periodico
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia (2014)
Blitterswijk, Marka van; Mullen, Bianca; Nicholson, Alexandra M.; Bieniek, Kevin F.; Heckman, Michael G.; Baker, Matthew C.; DeJesus‑Hernandez, Mariely; Finch, NiCole A.; Brown, Patricia H.; Murray, Melissa E.; Hsiung, Ging‑Yuek R.; Stewart, Heather; Karydas, Anna M.; Finger, Elizabeth; Kertesz, Andrew; Bigio, Eileen H.; Weintraub, Sandra; Mesulam, Marsel; Hatanpaa, Kimmo J.; White III, Charles L.; Strong, Michael J.; Beach, Thomas G.; Wszolek, Zbigniew K.; Lippa, Carol; Caselli, Richard; Petrucelli, Leonard; Josephs, Keith A.; Parisi, Joseph E.; Knopman, David S.; Petersen, Ronald C.; Mackenzie, Ian R.; Seeley, William W.; Grinberg, Lea T.; Miller, Bruce L.; Boylan, Kevin B.; Graff‑Radford, Neill R.; Boeve, Bradley F.; Dickson, Dennis W.; Rademakers, Rosa
Source: Acta Neuropathologica. Unidade: FM
Subjects: POLIMORFISMO, DOENÇAS NEURODEGENERATIVAS (ETIOLOGIA), MUTAÇÃO GENÉTICA, DEMÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BLITTERSWIJK, Marka van et al. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathologica, v. 127, n. 3, p. 397-406, 2014Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00401-013-1240-4. Acesso em: 27 set. 2024.
APA
Blitterswijk, M. van, Mullen, B., Nicholson, A. M., Bieniek, K. F., Heckman, M. G., Baker, M. C., et al. (2014). TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathologica, 127( 3), 397-406. doi:10.1007/s00401-013-1240-4
NLM
Blitterswijk M van, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, DeJesus‑Hernandez M, Finch NCA, Brown PH, Murray ME, Hsiung G‑YR, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White III CL, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff‑Radford NR, Boeve BF, Dickson DW, Rademakers R. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia [Internet]. Acta Neuropathologica. 2014 ; 127( 3): 397-406.[citado 2024 set. 27 ] Available from: http://link.springer.com/article/10.1007/s00401-013-1240-4
Vancouver
Blitterswijk M van, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, DeJesus‑Hernandez M, Finch NCA, Brown PH, Murray ME, Hsiung G‑YR, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, Hatanpaa KJ, White III CL, Strong MJ, Beach TG, Wszolek ZK, Lippa C, Caselli R, Petrucelli L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Mackenzie IR, Seeley WW, Grinberg LT, Miller BL, Boylan KB, Graff‑Radford NR, Boeve BF, Dickson DW, Rademakers R. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia [Internet]. Acta Neuropathologica. 2014 ; 127( 3): 397-406.[citado 2024 set. 27 ] Available from: http://link.springer.com/article/10.1007/s00401-013-1240-4
Artigo de periodico
Practical utility of amyloid and FDG-PET in an academic dementia center (2014)
Sánchez-Juan, Pascual; Ghosh, Pia M.; Hagen, Jayne; Gesierich, Benno; Henry, Maya; Grinberg, Lea T.; O'Neil, James P.; Janabi, Mustafa; Huang, Eric J.; Trojanowski, John Q.; Vinters, Harry V.; Gorno-Tempini, Marilu; Seeley, William W.; Boxer, Adam L.; Rosen, Howard J.; Kramer, Joel H.; Miller, Bruce L.; Jagust, William J.; Rabinovici, Gil D.
Source: Neurology. Unidade: FM
Subjects: DEMÊNCIA, DIAGNÓSTICO POR IMAGEM, DOENÇAS DEGENERATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SÁNCHEZ-JUAN, Pascual et al. Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology, v. 82, n. 3, p. 230-238, 2014Tradução . . Disponível em: https://doi.org/10.1212/WNL.0000000000000032. Acesso em: 27 set. 2024.
APA
Sánchez-Juan, P., Ghosh, P. M., Hagen, J., Gesierich, B., Henry, M., Grinberg, L. T., et al. (2014). Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology, 82( 3), 230-238. doi:10.1212/WNL.0000000000000032
NLM
Sánchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, O'Neil JP, Janabi M, Huang EJ, Trojanowski JQ, Vinters HV, Gorno-Tempini M, Seeley WW, Boxer AL, Rosen HJ, Kramer JH, Miller BL, Jagust WJ, Rabinovici GD. Practical utility of amyloid and FDG-PET in an academic dementia center [Internet]. Neurology. 2014 ; 82( 3): 230-238.[citado 2024 set. 27 ] Available from: https://doi.org/10.1212/WNL.0000000000000032
Vancouver
Sánchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, O'Neil JP, Janabi M, Huang EJ, Trojanowski JQ, Vinters HV, Gorno-Tempini M, Seeley WW, Boxer AL, Rosen HJ, Kramer JH, Miller BL, Jagust WJ, Rabinovici GD. Practical utility of amyloid and FDG-PET in an academic dementia center [Internet]. Neurology. 2014 ; 82( 3): 230-238.[citado 2024 set. 27 ] Available from: https://doi.org/10.1212/WNL.0000000000000032
Artigo de periodico
Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration (2014)
Scherling, Carole S.; Hall, Tracey; Berisha, Flora; Klepac, Kristen; Karydas, Anna; Coppola, Giovanni; Kramer, Joel H.; Rabinovici, Gil; Ahlijanian, Michael; Miller, Bruce L.; Seeley, William; Grinberg, Lea T.; Rosen, Howard; Meredith Jr., Jere; Boxe, Adam L.
Source: Annals of Neurology. Unidade: FM
Subjects: DOENÇAS NEURODEGENERATIVAS, LÍQUIDO CEFALORRAQUIDIANO, DEGENERAÇÃO NEURAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHERLING, Carole S. et al. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Annals of Neurology, v. 75, n. 1, p. 116-126, 2014Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/ana.24052/pdf. Acesso em: 27 set. 2024.
APA
Scherling, C. S., Hall, T., Berisha, F., Klepac, K., Karydas, A., Coppola, G., et al. (2014). Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Annals of Neurology, 75( 1), 116-126. doi:10.1002/ana.24052
NLM
Scherling CS, Hall T, Berisha F, Klepac K, Karydas A, Coppola G, Kramer JH, Rabinovici G, Ahlijanian M, Miller BL, Seeley W, Grinberg LT, Rosen H, Meredith Jr. J, Boxe AL. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration [Internet]. Annals of Neurology. 2014 ; 75( 1): 116-126.[citado 2024 set. 27 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/ana.24052/pdf
Vancouver
Scherling CS, Hall T, Berisha F, Klepac K, Karydas A, Coppola G, Kramer JH, Rabinovici G, Ahlijanian M, Miller BL, Seeley W, Grinberg LT, Rosen H, Meredith Jr. J, Boxe AL. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration [Internet]. Annals of Neurology. 2014 ; 75( 1): 116-126.[citado 2024 set. 27 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/ana.24052/pdf
Artigo de periodico
Progranulin Mutations as Risk Factors for Alzheimer Disease (2013)
Perry, David C.; Lehmann, Manja; Yokoyama, Jennifer S.; Karydas, Anna; Lee, Jason JiYong; Coppola, Giovanni; Grinberg, Lea T.; Geschwind, Dan; Seeley, William W.; Miller, Bruce L.; Rosen, Howard; Rabinovici, Gil
Source: JAMA Neurology. Unidade: FM
Subjects: FATORES DE RISCO, DOENÇAS NEURODEGENERATIVAS, DOENÇA DE ALZHEIMER, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERRY, David C. et al. Progranulin Mutations as Risk Factors for Alzheimer Disease. JAMA Neurology, v. 70, n. 6, p. 774-778, 2013Tradução . . Disponível em: https://doi.org/10.1001/2013.jamaneurol.393. Acesso em: 27 set. 2024.
APA
Perry, D. C., Lehmann, M., Yokoyama, J. S., Karydas, A., Lee, J. J. Y., Coppola, G., et al. (2013). Progranulin Mutations as Risk Factors for Alzheimer Disease. JAMA Neurology, 70( 6), 774-778. doi:10.1001/2013.jamaneurol.393
NLM
Perry DC, Lehmann M, Yokoyama JS, Karydas A, Lee JJY, Coppola G, Grinberg LT, Geschwind D, Seeley WW, Miller BL, Rosen H, Rabinovici G. Progranulin Mutations as Risk Factors for Alzheimer Disease [Internet]. JAMA Neurology. 2013 ; 70( 6): 774-778.[citado 2024 set. 27 ] Available from: https://doi.org/10.1001/2013.jamaneurol.393
Vancouver
Perry DC, Lehmann M, Yokoyama JS, Karydas A, Lee JJY, Coppola G, Grinberg LT, Geschwind D, Seeley WW, Miller BL, Rosen H, Rabinovici G. Progranulin Mutations as Risk Factors for Alzheimer Disease [Internet]. JAMA Neurology. 2013 ; 70( 6): 774-778.[citado 2024 set. 27 ] Available from: https://doi.org/10.1001/2013.jamaneurol.393
Artigo de periodico
TDP-43 frontotemporal lobar degeneration and autoimmune disease (2013)
Miller, Zachary A.; Rankin, Katherine P.; Graff-Radford, Neill R.; Takada, Leonel T.; Sturm, Virginia E.; Cleveland, Clare M.; Criswell, Lindsey A.; Jaeger, Philipp A.; Stan, Trisha; Heggeli, Kristin A.; Hsu, Sandy Chan; Karydas, Anna; Khan, Baber K.; Grinberg, Lea T.; Gorno-Tempini, Maria Luisa; Boxer, Adam L.; Rosen, Howard J.; Kramer, Joel H.; Coppola, Giovanni; Geschwind, Daniel H.; Rademakers, Rosa; Seeley, William W.; Wyss-Coray, Tony; Miller, Bruce L.
Source: Journal of Neurology, Neurosurgery and Psychiatry. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, DOENÇA DE ALZHEIMER, DEMÊNCIA, REGRESSÃO LOGÍSTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MILLER, Zachary A. et al. TDP-43 frontotemporal lobar degeneration and autoimmune disease. Journal of Neurology, Neurosurgery and Psychiatry, v. 84, n. 9, p. 956-962, 2013Tradução . . Disponível em: https://doi.org/10.1136/jnnp-2012-304644. Acesso em: 27 set. 2024.
APA
Miller, Z. A., Rankin, K. P., Graff-Radford, N. R., Takada, L. T., Sturm, V. E., Cleveland, C. M., et al. (2013). TDP-43 frontotemporal lobar degeneration and autoimmune disease. Journal of Neurology, Neurosurgery and Psychiatry, 84( 9), 956-962. doi:10.1136/jnnp-2012-304644
NLM
Miller ZA, Rankin KP, Graff-Radford NR, Takada LT, Sturm VE, Cleveland CM, Criswell LA, Jaeger PA, Stan T, Heggeli KA, Hsu SC, Karydas A, Khan BK, Grinberg LT, Gorno-Tempini ML, Boxer AL, Rosen HJ, Kramer JH, Coppola G, Geschwind DH, Rademakers R, Seeley WW, Wyss-Coray T, Miller BL. TDP-43 frontotemporal lobar degeneration and autoimmune disease [Internet]. Journal of Neurology, Neurosurgery and Psychiatry. 2013 ; 84( 9): 956-962.[citado 2024 set. 27 ] Available from: https://doi.org/10.1136/jnnp-2012-304644
Vancouver
Miller ZA, Rankin KP, Graff-Radford NR, Takada LT, Sturm VE, Cleveland CM, Criswell LA, Jaeger PA, Stan T, Heggeli KA, Hsu SC, Karydas A, Khan BK, Grinberg LT, Gorno-Tempini ML, Boxer AL, Rosen HJ, Kramer JH, Coppola G, Geschwind DH, Rademakers R, Seeley WW, Wyss-Coray T, Miller BL. TDP-43 frontotemporal lobar degeneration and autoimmune disease [Internet]. Journal of Neurology, Neurosurgery and Psychiatry. 2013 ; 84( 9): 956-962.[citado 2024 set. 27 ] Available from: https://doi.org/10.1136/jnnp-2012-304644

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em